Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Our company
  • AZ on the issues
  • Investors
  • Corporate responsibility
  • Newsroom
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
    • Media resources
  • US web sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of all news articles published within 12-months, starting from most recent.

Subscribe to RSS news feed

• Pages
• 1
• 2
• 3
• 4
• Next

• • Aug 14, 2008
  • Abbott and AstraZeneca expand relationship to include co-promotion of CRESTOR®  
• • Jul 31, 2008
  • AstraZeneca PLC second quarter and half year results 2008  
• • Jul 23, 2008
  • AstraZeneca survey: Healthcare professionals leading source of information on company’s prescription savings programs  
• • Jul 23, 2008
  • AstraZeneca and Bristol-Myers Squibb submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA™ (saxagliptin) for the treatment of type 2 diabetes  
• • Jul 10, 2008
  • AstraZeneca supports new PhRMA code on interactions with healthcare providers  
• • Jul 1, 2008
  • Summary Judgment granted for SEROQUEL® patent litigation  
• • Jun 26, 2008
  • AstraZeneca announces senior management changes at biologics business unit, MedImmune  
• • Jun 24, 2008
  • AstraZeneca partners with St. Vincent de Paul Charitable Pharmacy to provide medicine for uninsured  
• • Jun 17, 2008
  • AstraZeneca and Columbia University Medical Center sign strategic research collaboration to develop novel therapeutics for diabetes and obesity  
• • Jun 7, 2008
  • ONGLYZA™ (saxagliptin) demonstrated significant reductions in key measures of glucose control in treatment naïve people with type 2 diabetes  
• • Jun 4, 2008
  • AstraZeneca submits an sNDA for SYMBICORT® for the treatment of asthma in children as young as age six  
• • Jun 3, 2008
  • Nationwide bus tour rolls into Dover urging Americans to join the fight to defeat cancer  
• • May 30, 2008
  • AstraZeneca submits sNDA for NEXIUM® I.V. for peptic ulcer bleed indication  
• • May 27, 2008
  • Study of twins reveals genetic susceptibility to COPD chronic obstructive pulmonary disease  
• • May 22, 2008
  • AstraZeneca supports transparency legislation on payments to healthcare providers  
• • May 20, 2008
  • Study analyzed SYMBICORT® in children with persistent asthma  
• • May 20, 2008
  • New patient satisfaction study with budesonide/formoterol combination therapy and fluticasone/salmeterol combination therapy in adults with asthma  
• • May 19, 2008
  • New survey reveals Hispanic-Americans are taking steps to better understand and manage GERD  
• • May 14, 2008
  • Working in partnerships to help those in need in Myanmar (Burma) and elsewhere  
• • May 14, 2008
  • FDA approves AstraZeneca’s SEROQUEL® for maintenance treatment in bipolar disorder  

• Pages
• 1
• 2
• 3
• 4
• Next

Page tools

• Print
• Bookmark this page